Stock HNGZY HANGZHOU TIGERMED CONSULTING CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

News Hangzhou Tigermed Consulting Co., Ltd OTC Markets

Equities

HNGZY

US41044T1088

Market Closed - OTC Markets
Other stock markets
 10:13:36 19/12/2023 pm IST 		5-day change 1st Jan Change
4.2 USD -4.55% Intraday chart for Hangzhou Tigermed Consulting Co., Ltd -.--% -.--%
18/06 Hangzhou Tigermed Consulting Co., Ltd Announces Executive Changes CI
14/06 Tigermed Consulting Assures Normal Operations Amid Share Price Fluctuations MT

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Hangzhou Tigermed Consulting Co., Ltd Announces Executive Changes
CI
Tigermed Consulting Assures Normal Operations Amid Share Price Fluctuations
MT
Hangzhou Tigermed Consulting Co., Ltd commences an Equity Buyback Plan for CNY 1,000 million worth of its shares, under the authorization approved on April 30, 2024.
CI
Hangzhou Tigermed Consulting’s Profit Down 59% in Q1
MT
Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the First Quarter Ended March 30, 2024
CI
Tigermed Consulting's Profit, Revenue Climb in 2023
MT
Hangzhou Tigermed Consulting Co., Ltd Announces Final Dividend for the Year Ended December 31, 2023, Payable on 18 July 2024
CI
Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Hangzhou Tigermed Consulting Co., Ltd Announces Executive Changes
CI
China Healthcare Stocks Rally on Hopes for Government Support
DJ
China stocks steady, helped by biotech rally; Wuxi Apptec drags Hong Kong shares
RE
Nomura Downgrades Hangzhou Tigermed Consulting to Neutral From Buy, Adjusts Price Target to 49.61 Yuan From 75.72 Yuan
MT
Nomura Downgrades Tigermed to Neutral From Buy, Adjusts Price Target to HK$32.69 From HK$57.77
MT
Hangzhou Tigermed Consulting Plans Up to 1 Billion Yuan Share Repurchase; Shares Jump 4%
MT
Hangzhou Tigermed Consulting Co., Ltd announces an Equity Buyback for CNY 1,000 million worth of its shares.
CI
Hangzhou Tigermed Consulting Co., Ltd authorizes a Buyback Plan.
CI
Hangzhou Tigermed Consulting Co., Ltd authorizes a Buyback Plan.
CI
Nomura Adjusts Hangzhou Tigermed Consulting' Price Target to 75.72 Yuan from 83.50 Yuan, Keeps at Buy
MT
Nomura Adjusts Hangzhou Tigermed Consulting' Price Target to HK$57.77 from HK$64.46, Keeps at Buy
MT
Hangzhou Tigermed Consulting's Profit Up 19% in Q3
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300347 Stock
  4. HNGZY Stock
  5. News Hangzhou Tigermed Consulting Co., Ltd